Brécier, Aurélie https://orcid.org/0000-0002-6316-1624
Bannerman, Courtney A. https://orcid.org/0000-0003-0118-0210
Xie, Yu-Feng https://orcid.org/0000-0001-8384-4177
Dedek, Christopher https://orcid.org/0000-0002-3526-1257
Zacharias, Amanda M. https://orcid.org/0000-0002-5598-0232
O’Connor, Ciara D. https://orcid.org/0000-0003-3211-2237
Rickert Llàcer, Aitana https://orcid.org/0009-0002-4633-6485
Miller, Steven D.
Li, Vina W. https://orcid.org/0000-0003-2496-5598
Meier, Christina https://orcid.org/0009-0006-5464-9018
Ballantyne, Laurel L. https://orcid.org/0000-0002-2032-1341
Du Bois, Justin https://orcid.org/0000-0001-7847-1548
Duan, Qingling https://orcid.org/0000-0003-4467-7024
Prescott, Steven A. https://orcid.org/0000-0002-3827-4512
Ghasemlou, Nader https://orcid.org/0000-0002-1696-7342
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (PJT-497592)
Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (RGPIN-05604)
Multiple Sclerosis Society of Canada (3316)
MS Canada
Article History
Received: 9 April 2025
Accepted: 20 May 2026
First Online: 1 June 2026
Competing interests
: C.D. and S.A.P. have filed a patent for RAMalgo and are co-founders of Robotic Algometry Inc, which produces RAMalgo. All other authors declare no competing interests.